Phenominer

	Submit Data \| Help \| Video Tutorials \| News \| Publications \| Download \| REST API \| Citing RGD \| Contact
	Search RGD Grant Resources Citing RGD About Us Contact Us Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease Find Models new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive Pathways Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
	Advanced Search (OLGA)

Phenominer Database Results (6 results)

Colored By:

Table "column sort" updates the order of the bars in the chart.

Strain	Phenotype	Conditions	Study	Experiment Name	Sex	Age	# of Animals	Value	Units	SEM	SD	Method	Method Duration	Post Insult Time Value	Record ID	Study ID
SS-Renem1Mcwi+/+	retroperitoneal fat pad weight to body weight ratio	controlled sodium content diet (0.4 %) (for 49 days)	Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.	retroperitoneal fat pad mass	female	70 days	8	0.32	%	0.02	0.06	digital scale post excision weight measurement	0.0	0	98310	2038
SS-Renem1Mcwi+/-	retroperitoneal fat pad weight to body weight ratio	controlled sodium content diet (0.4 %) (for 49 days)	Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.	retroperitoneal fat pad mass	male	70 days	9	0.49	%	0.05	0.15	digital scale post excision weight measurement	0.0	0	98308	2038
SS-Renem1Mcwi+/+	retroperitoneal fat pad weight to body weight ratio	controlled sodium content diet (0.4 %) (for 49 days)	Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.	retroperitoneal fat pad mass	male	70 days	5	0.44	%	0.07	0.16	digital scale post excision weight measurement	0.0	0	98307	2038
SS-Renem1Mcwi+/-	retroperitoneal fat pad weight to body weight ratio	controlled sodium content diet (0.4 %) (for 49 days)	Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.	retroperitoneal fat pad mass	male	70 days	8	0.23	%	0.04	0.11	digital scale post excision weight measurement	0.0	0	98309	2038
SS-Renem1Mcwi+/-	retroperitoneal fat pad weight to body weight ratio	controlled sodium content diet (0.4 %) (for 49 days)	Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.	retroperitoneal fat pad mass	female	70 days	8	0.27	%	0.03	0.08	digital scale post excision weight measurement	0.0	0	98311	2038
SS-Renem1Mcwi+/-	retroperitoneal fat pad weight to body weight ratio	controlled sodium content diet (0.4 %) (for 49 days)	Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.	retroperitoneal fat pad mass	female	70 days	4	0.17	%	0.02	0.04	digital scale post excision weight measurement	0.0	0	98312	2038

Contact Us | About Us | Jobs at RGD

© Bioinformatics Program, HMGC at the Medical College of Wisconsin

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.
NHLBI Logo